Trial
NCT07313774
A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Maintenance of Healing in Participants With Healed Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Cinclus Pharma Holding AB
Collaborators
—
Condition
GERD (Gastroesophageal Reflux Disease)
Intervention
Linaprazan glurate - High dose
Why stopped
Strategic desicion by Sponsor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-28